Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA1 | P42261 | 1/20 | 0.39 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.39 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.39 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | RARA | P10276 | 1/20 | 0.34 |
| ▸ | RARB | P10826 | 1/20 | 0.34 |
| ▸ | RARG | P13631 | 1/20 | 0.34 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | ERN1 | O75460 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30292091 | 1.00 | GRIA1 (0.39) | GRIA1GRIA2GRIA3GRIA4ALDH1A1 | |
| SCHEMBL5396132 | 1.00 | GRIA1 (0.39) | GRIA1GRIA2GRIA3GRIA4ALDH1A1 | |
| SCHEMBL9078609 | 1.00 | GRIA1 (0.39) | GRIA1GRIA2GRIA3GRIA4ALDH1A1 | |
| SCHEMBL5611213 | 1.00 | GRIA1 (0.39) | GRIA1GRIA2GRIA3GRIA4ALDH1A1 | |
| SCHEMBL30754351 | 1.00 | GRIA1 (0.39) | GRIA1GRIA2GRIA3GRIA4ALDH1A1 | |
| SCHEMBL9078615 | 1.00 | GRIA1 (0.39) | GRIA1GRIA2GRIA3GRIA4ALDH1A1 | |
| SCHEMBL29369649 | 1.00 | GRIA1 (0.39) | GRIA1GRIA2GRIA3GRIA4ALDH1A1 | |
| SCHEMBL9215398 | 0.89 | RXRA (0.42) | GRIA1GRIA2GRIA3GRIA4ALDH1A1 | |
| Acetone SCHEMBL4711588 | 0.80 | RXRA (0.36) | GRIA1GRIA2GRIA3GRIA4ALDH1A1 | |
| SCHEMBL9211089 | 0.80 | RARG (0.47) | GRIA1GRIA2GRIA3GRIA4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0664286-B1 | Tetralin nitriles, their use as ingredients for perfumes and oxime intermediates for their preparation | FIRMENICH & CIE (CH) | 1998-04-22 | — | — | EP | claimed |
| US-5442124-A | Process for the preparation of novel aromatic compounds | FIRMENICH SA (CH) | 1995-08-15 | — | — | US | claimed |
| EP-0664286-A1 | Tetralin nitriles, their use as ingredients for perfumes and oxime intermediates for their preparation | FIRMENICH SA (CH) | 1995-07-26 | — | — | EP | claimed |
| EP-0405427-B1 | Aromatic compounds, process for their preparation and their use as perfuming ingredients | FIRMENICH & CIE (CH) | 1995-03-29 | — | — | EP | claimed |
| US-5162588-A | Muky type odor; colognes, shaving lotions, soaps, bath gels, shampoos, hair care products | FIRMENICH S.A. (CH) | 1992-11-10 | — | — | US | claimed |
| EP-0405427-A2 | Aromatic compounds, process for their preparation and their use as perfuming ingredients | FIRMENICH SA (CH) | 1991-01-02 | — | — | EP | claimed |
| JP-3044348-A | — | — | None | — | — | JP | disclosed |
| US-11203729-B2 | Unsaturated macrocyclic epoxide as perfuming ingredient | FIRMENICH SA (CH) | 2021-12-21 | — | — | US | disclosed |
| US-20180362881-A1 | UNSATURATED MACROCYCLIC EPOXIDE AS PERFUMING INGREDIENT | FIRMENICH SA (CH) | 2018-12-20 | — | — | US | disclosed |
| EP-3134498-B1 | UNSATURED MACROCYCLIC EPOXIDE AS PERFUMING INGREDIENT | FIRMENICH & CIE (CH) | 2018-01-31 | — | — | EP | disclosed |
| US-20170058236-A1 | UNSATURATED MACROCYCLIC EPOXIDE AS PERFUMING INGREDIENT | FIRMENICH SA (CH) | 2017-03-02 | — | — | US | disclosed |
| EP-2935180-B1 | SAGE ODORANT | FIRMENICH & CIE (CH) | 2016-09-21 | — | — | EP | disclosed |
| US-9284513-B2 | Sage odorant | FIRMENICH SA (CH) | 2016-03-15 | — | — | US | disclosed |
| EP-0664286-A1 | Tetralin nitriles, their use as ingredients for perfumes and oxime intermediates for their preparation | FIRMENICH SA (CH) | 1995-07-26 | — | — | EP | disclosed |
| EP-0405427-B1 | Aromatic compounds, process for their preparation and their use as perfuming ingredients | FIRMENICH & CIE (CH) | 1995-03-29 | — | — | EP | disclosed |
| US-5324875-A | Musk odor | FIRMENICH SA (CH) | 1994-06-28 | — | — | US | disclosed |
| US-5185318-A | Aromatic compounds, a process for preparation thereof and use of same as perfuming ingredients | FIRMENICH S.A. (CH) | 1993-02-09 | — | — | US | disclosed |
| US-5162588-A | Muky type odor; colognes, shaving lotions, soaps, bath gels, shampoos, hair care products | FIRMENICH S.A. (CH) | 1992-11-10 | — | — | US | disclosed |
| JP-H0344348-A | NOVEL AROMATIC COMPOUND, PREPARATION THEREOF, PERFUMING COMPOSITION OR PERFUMED ARTICLE CONTAINING THE SAME, METHOD TO IMPROVE, EMPHASIZE OR CHANGE PERFUME CHARACTERISTICS AND INTERMEDIATE OF THE SAME | FIRMENICH SA | 1991-02-26 | — | — | JP | disclosed |
| EP-0405427-A2 | Aromatic compounds, process for their preparation and their use as perfuming ingredients | FIRMENICH SA (CH) | 1991-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180362881-A1 | UNSATURATED MACROCYCLIC EPOXIDE AS PERFUMING INGREDIENT | PTGES, TECR, EPHX2 | GRIA1 4030/4885GRIA2 4131/4885GRIA3 4589/4885 |
| US-20170058236-A1 | UNSATURATED MACROCYCLIC EPOXIDE AS PERFUMING INGREDIENT | PTGIS, PTGES, VKORC1 | GRIA1 3596/4885GRIA2 3683/4885GRIA3 4018/4885 |
| US-11203729-B2 | Unsaturated macrocyclic epoxide as perfuming ingredient | PTGES, TECR, EPHX2 | GRIA1 4030/4885GRIA2 4131/4885GRIA3 4589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.